Recently published studies assert that Ozempic significantly increases the risk of developing a rare eye condition called non ...

The European Union’s drug regulator said it would review two studies that link Novo Nordisk’s blockbuster diabetes drug ...

A recent meta-analysis of 69 clinical trials found the risk for ischemic optic neuropathy from GLP-1 therapy is too low to be ...

With U.S. headquarters in Plainsboro, Novo Nordisk told NJBIZ, "NAION is a very rare eye disease, and it is not an adverse ...

Danish studies have found a potential link between the diabetes drug Ozempic and a rare eye condition called non-arteritic ...

Following an appeal by the Danish Medicines Agency, the European Union’s drug regulator will review two new studies that have ...

Several recent studies have found a possible connection between semaglutide use and a rare condition that causes sudden ...

Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated ...

The European Union's drug regulator said it would assess two new Danish studies that link Novo Nordisk's popular diabetes ...

GLP weight-loss drug Ozempic has reportedly been linked to a rare form of vision loss, known as non-arteritic anterior ischemic optic neuropathy (NAION). The study, which has yet to be peer-reviewed, ...

A vision-threatening eye condition may be linked to Ozempic. Meanwhile, Nearly 80% of doctors are using telemedicine weekly, ...

Denmark's drug regulator asks EMA to investigate potential link between Novo Nordisk's diabetes drug Ozempic and rare eye ...